abstract |
The present invention is selected from the group consisting of a pharmaceutically acceptable carrier and (i) the amino acid sequence (SEQ ID NO: 10) of a long-chain isoform of RdCVF2 gene in human (Homo sapiens), its ortholog, derivative and fragment A polypeptide comprising an amino acid sequence, (ii) a polynucleotide encoding the polypeptide, (iii) a vector comprising the polynucleotide, and (iv) a genetically engineered host cell expressing the polypeptide, A pharmaceutical composition comprising a compound selected from the group consisting of: the use of such a composition for the manufacture of a medicament for treating and / or preventing a neurodegenerative disease in a subject; It relates to a method for testing a subject having or suspected of having a predisposition thereto. |